Monash University

The Clinical Psychedelic Lab, established in 2020, within the Dept Psychiatry at Monash University is the first of its kind in Australia, leading the development and implementation of psychedelic therapies. The lab has played a central role in establishing the field of clinical psychedelic research in Australia.

The Lab is comprised of a multidisciplinary team of clinical research scientists, psychiatrists, psychologists, psychotherapists, nurses, ethicists, statisticians, social scientists, lived-experience advisors, and students. Led by Dr Paul Liknaitzky, the Clinical Psychedelic Lab has the largest and most experienced group of psychedelic scientists, clinicians, and trainers in the country.

Areas the Lab focuses on include expanding psychedelic treatment into new indications, exploring synergies between psychedelics and various psychotherapeutic and behavioral interventions, investigating therapeutic mechanisms, predicting clinical response, exploring and mitigating under-examined risks, translating evidence into best clinical practice, delivering next-generation therapist training, assessing cost-effectiveness, and improving access and affordability.

The Lab’s research mainly happens within their purpose-built research facility in Melbourne, Australia.